ALC:NYSE
Alcon AG
US$76.55
arrow_downward
-0.98%(-0.76) 1D
US$76.55
0.00% (0.00)
bedtimeAfter hours
Closed: ኖቬም 5, 4:00:04 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
US$77.17
High
US$77.82
Low
US$76.18
Mkt. cap
31.23 ቢ
Avg. vol.
1.80 ሚ
Volume
2.63 ሚ
52-wk high
US$87.64
52-wk low
US$61.84
Beta
0.87
Shares outstanding
483.40 ሚ
No. of employees
25 ሺ
Open
US$77.17
High
US$77.82
Low
US$76.18
Mkt. cap
31.23 ቢ
Avg. vol.
1.80 ሚ
Volume
2.63 ሚ
52-wk high
US$87.64
52-wk low
US$61.84
Beta
0.87
Shares outstanding
483.40 ሚ
No. of employees
25 ሺ
News stories
From web sources and news partners
Yahoo Finance
·
ከ10 ሰዓቶች በፊት
Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Zacks
·
ከ10 ሰዓቶች በፊት
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 ሺ
Founded1945
Headquartersዠኔቭ, Geneva, ስዊዘርላንድ
SectorHealth Care
IndustryMedical device
Websitealcon.com